Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Titan Medical Inc. (T:TMD)

Business Focus: Biotechnology & Medical Research

Nov 16, 2020 07:00 am ET
Titan Medical Reports Third Quarter Financial Results
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces financial results for the three and nine months ended September 30, 2020, highlighted by the Company’s improved cash position, which, as of September 30, 2020, reflects a positive difference of approximately $24 million compared to its cash position at December 31, 2019.
Oct 26, 2020 07:30 am ET
Titan Medical Announces Achievement of $10 Million Technical Milestone Under Medtronic Development and License Agreement
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed the first technical milestone under the development and license agreement with Medtronic plc (“Medtronic”) (NYSE: MDT), and is due to receive a U.S. $10 million payment.
Oct 07, 2020 08:00 am ET
Titan Medical Announces Election of Three New Independent Members to Its Board of Directors
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of robotic surgical technologies for single access surgery, today announced the election of Paul Cataford, Anthony J. Giovinazzo and Cary G. Vance to its Board of Directors. All three individuals were nominated by the Board and were approved by shareholders voting at the Company’s Annual and Special Meeting of Shareholders on September 30th (the “AGM”). Subsequent to the AGM, the Board held a meeting and the following elections to Board commi
Oct 01, 2020 08:00 am ET
Titan Medical Reports Voting Results from Annual and Special Meeting of Shareholders
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of robotic surgical technologies, announced the voting results from the Company’s Annual and Special Meeting of its Shareholders held on Wednesday, September 30, 2020.
Sep 21, 2020 08:00 am ET
Titan Medical Reveals New Robotic Surgical System Brand Identity and Updated Corporate Brand Identity
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of robotic surgical technologies, announced today the launch of a new name and brand identity for its robotic surgical system under development, the Enos™ robotic single access surgical system.
Sep 17, 2020 08:00 am ET
Titan Medical Announces Intellectual Property Portfolio Expansion with Issuance of Robotic Surgery Patents Related to Camera and System Control
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has recently been issued two U.S. patents, increasing its global intellectual property portfolio to 58 issued patents and 84 patent applications. The Company has also received notices of allowance in 17 other patent applications and accordingly anticipates their issuance in the coming months.
Sep 09, 2020 08:00 am ET
Titan Medical Inc. to Present at the H.C. Wainwright Virtual Conference
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today announced that it is scheduled to present at the H.C. Wainwright Investor Conference on Monday, September 14, 2020 at 2:00 PM ET. David McNally, President and CEO of Titan will be presenting to a live virtual audience available by webcast at
Sep 08, 2020 08:00 am ET
Titan Medical Announces Chief Financial Officer Retirement and Successor Appointment
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today announced its Chief Financial Officer (CFO) Stephen Randall will retire after more than 10 years with Titan. As part of the Company’s succession planning process, Monique L. Delorme, currently Vice President, Finance at Titan, will be promoted to CFO effective October 1, 2020.
Aug 26, 2020 09:00 am ET
Titan Medical Inc. to Present at the LD 500 Virtual Conference
TORONTO, ON / ACCESSWIRE / August 26, 2020 /Titan Medical Inc. ("Titan" or the "Company") (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today announced that it is scheduled to present at the LD 500 investor conference on Wednesday, September 2, 2020 at 11:20 AM ET. David McNally, President and CEO of Titan will be presenting to a live virtual audience available by webcast at http://www.webcaster4.com/webcast/page/2019/36162.
Aug 12, 2020 05:30 pm ET
Titan Medical Reports Second Quarter 2020 Financial Results
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces financial results for the three and six months ended June 30, 2020.
Aug 10, 2020 08:00 pm ET
Titan Medical Confirms Receipt of Deficiency Notice From Nasdaq
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today announced that on August 5, 2020, the Company received a deficiency notice from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5550(a)(2) since the closing bid price for the Company's common shares (the “Shares”) listed on Nasdaq was below US$1.00 for 30 consecutive business days.
Jul 30, 2020 08:00 am ET
Titan Medical Reports Design Enhancements to Single-Port Robotic Surgical Instruments on Product Development Resumption
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has completed design enhancements to instruments compatible for use with its single-port robotic surgical system. As previously disclosed, the Company resumed development of instruments for its single-port robotic surgical system in June 2020 following the completion of a financing for gross proceeds of US$18 million.
Jul 27, 2020 08:00 am ET
Titan Medical to Present at the Society of Robotic Surgery 2020 World Robotic Symposium
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that David McNally, President and CEO of Titan Medical, will present in the plenary session titled “Future Robotic Platforms” on Saturday, August 1 at the Society of Robotic Surgery (SRS) 2020 World Robotic Symposium. This industry-focused plenary session will feature executives from companies recognized for current and promising technology platforms in robotic surgery.
Jul 14, 2020 08:00 am ET
Titan Medical Issues Shareholder Update Letter
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today issued an update letter to its shareholders. The letter, authored by David McNally, President & CEO, Chairman, may be found on the Company’s website and a full text of the letter follows.
Jun 25, 2020 08:00 am ET
Titan Medical Promotes Globally Recognized Intellectual Property Strategy Leader to Vice President and General Counsel
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that its head of intellectual property, Jasminder Brar, has been promoted to Vice President of Legal, IP and Strategic Initiatives, and General Counsel. Mr. Brar has lead Titan’s strategic IP efforts since 2011 and is recognized as a global IP strategy leader, having been named to the IAM Strategy 300: The World’s Leading IP Strategists since 2015. In this expanded role, Mr. Brar will also s
Jun 22, 2020 08:00 am ET
Titan Medical Reports Full Compliance with Nasdaq Listing Criteria
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that on June 18, 2020, The Nasdaq Stock Market LLC (“Nasdaq”) staff determined that the Company has cured the Market Value of Listed Securities and bid price deficiencies and has regained full compliance with all applicable criteria for continued listing and trading on The Nasdaq Capital Market. Accordingly, the Nasdaq Hearings Panel scheduled for July 16, 2020 has been cancelled.
Jun 16, 2020 11:02 am ET
IIROC Trading Halt - TMD
TORONTO, June 16, 2020 /CNW/ - The following issues have been halted by IIROC:
Jun 16, 2020 10:37 am ET
IIROC Trade Resumption - TMD
TORONTO, June 16, 2020 /CNW/ - Trading resumes in:
Jun 15, 2020 08:00 am ET
Titan Medical Establishes U.S. Subsidiary to Strengthen its Research and Product Development Activities
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has established Titan Medical USA Inc. as a wholly owned U.S. subsidiary. The subsidiary will be based in Chapel Hill, North Carolina at a facility that will initially be used for research and development activities. The facility includes a custom buildout, the costs for which are included in monthly lease payments.
Jun 11, 2020 02:24 pm ET
Titan Medical Announces Closing of US$18.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, is pleased to announce today that it closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 18,000,000 common shares of the Company (the “Common Shares”) or Common Shares equivalents at a price of US$1.00 per Common Share or Common Share equivalent and 9,000,000 Common Share purchase warrants (each, a “
Jun 11, 2020 07:30 am ET
Titan Medical Appoints Phillip L. McStotts, CPA, CGMA to Board of Directors
Mr. McStotts is a successful entrepreneur with 30 years of experience in the medical device industry, having been a Chief Financial Officer in both public and private companies. He has co-founded start-up companies that have commercialized best-in-class surgical, life and organ support, diagnostic and home-care capital equipment and disposables. He has raised investment capital from institutional and retail investors, angel investors, venture capital, private equity, strategic partners, and a healthcare royalty fund. Mr. McStotts negotiated a reverse-merger into a public company and thereafter
Jun 10, 2020 10:20 am ET
IIROC Trade Resumption - TMD
TORONTO, June 10, 2020 /CNW/ - Trading resumes in:
Jun 10, 2020 10:15 am ET
IIROC Trading Halt - TMD
TORONTO, June 10, 2020 /CNW/ - The following issues have been halted by IIROC:
Jun 09, 2020 02:22 pm ET
IIROC Trade Resumption - TMD
TORONTO, June 9, 2020 /CNW/ - Trading resumes in:
Jun 09, 2020 02:18 pm ET
IIROC Trading Halt - TMD
TORONTO, June 9, 2020 /CNW/ - The following issues have been halted by IIROC:
Jun 09, 2020 12:42 pm ET
IIROC Trade Resumption - TMD
TORONTO, June 9, 2020 /CNW/ - Trading resumes in:
Jun 09, 2020 12:37 pm ET
IIROC Trading Halt - TMD
TORONTO, June 9, 2020 /CNW/ - The following issues have been halted by IIROC:
Jun 09, 2020 08:00 am ET
Titan Medical Announces Settlement of Pending Litigation With Naglreiter Consulting, LLC
Titan Medical Inc. (“Titan” or “Titan Medical”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has entered into a settlement agreement with Naglreiter Consulting, LLC, d/b/a Naglreiter MDDO (“Naglreiter”) to settle claims in the lawsuit styled Naglreiter Consulting LLC, d/b/a Naglreiter MDDO v. Titan Medical Inc. (Case No. 0:19-cv-62574) pending in the United States District Court for the Southern District of Florida.
Jun 08, 2020 09:24 am ET
Titan Medical Announces US$18.0 Million Registered Direct Offering Priced At-the-Market
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it has entered into definitive agreements with a single healthcare-focused institutional investor that provide for the purchase and sale of 18,000,000 common shares of the Company (the “Common Shares”) (or Common Shares equivalents) at a per share purchase price of US$1.00 per Co
Jun 04, 2020 07:30 am ET
Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan
Titan Medical Inc. (“Titan” or “Titan Medical”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has entered into a development and license agreement with Medtronic plc (“Medtronic”) (NYSE: MDT) to further the development of robotic assisted surgical technologies, as well as a separate license agreement with Medtronic in respect of certain intellectual property of Titan.
May 27, 2020 08:00 am ET
Titan Medical Receives Nasdaq Delisting Notification and Discloses Plans for Appeal
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that on May 26, 2020 it received a Staff Delisting Determination letter (the “Determination”) from The Nasdaq Stock Market, LLC setting forth a determination to delist the Company's common shares from The Nasdaq Capital Market as a result of the Company's failure to comply with the Listing Rule 5550(b) which requires a minimum of $2.5 million in stockh
May 13, 2020 04:30 pm ET
Titan Medical Reports First Quarter 2020 Financial Results
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the three months ended March 31, 2020.
May 06, 2020 09:29 am ET
Titan Medical Announces Closing of US$2.0 Million Registered Direct Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 5,514,504 common shares of the Company (the “Common Shares”) at a price of US$0.36268 per Common Share and 2,757,252 unregistered Common Share purchase warr
May 04, 2020 09:00 am ET
Titan Medical Announces US$2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it has entered into definitive agreements with institutional investors that provide for the purchase and sale of 5,514,504 common shares of the Company (the “Common Shares”) at a per share purchase price of US$0.36268 per Common Share in a registered direct offering priced at-the
Apr 30, 2020 08:00 am ET
Titan Medical and Its Primary Product Development Supplier Agree to Payment Plan for Outstanding Amounts and Resumption of Development Services
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has entered into a letter agreement (“Letter Agreement”) with its primary product development supplier (“Primary Supplier”) for the payment of outstanding payables.
Apr 29, 2020 08:50 am ET
Titan Medical Announces $1.5 Million Senior Secured Loan Facility With a Leading Global Medical Technology Company
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has closed a US$1.5 million senior secured loan facility (“Loan Facility”) from a leading global medical technology company. The Loan Facility has an interest rate of 8% per annum and is repayable not later than April 29, 2023.
Mar 30, 2020 09:33 pm ET
Titan Medical Reports 2019 Financial Results
Titan Medical Inc. (“Titan” or “the Company”) (TSX: TMD) (NASDAQ: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the twelve months ended December 31, 2019.
Mar 27, 2020 11:37 am ET
Titan Medical Announces Closing of US$1.2 Million Registered Direct Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it closed its previously announced registered direct offering for the purchase and sale of 7,000,000 common shares of the Company (the “Common Shares”) at a purchase price of US$0.17 per Common Share and 3,500,000 Common Share purchase warrants (each, a “Warrant”), resulting in t
Mar 26, 2020 08:16 am ET
Titan Medical Expands and Strengthens Global Intellectual Property Portfolio With Issuance of Robotic Surgery Patents
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces that its global intellectual property portfolio has increased to 49 issued patents and 86 patent applications, including the recent granting and filing of patent applications directed at innovative robotic surgery technologies.
Mar 25, 2020 08:58 am ET
Titan Medical Announces US$1.2 Million Registered Direct Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it has entered into definitive agreements with institutional investors that provide for the purchase and sale of 7,000,000 common shares of the Company (the “Common Shares”) at a per share purchase price of $0.17 per Common Share and 3,500,000 Common Share purchase warrants (each
Feb 11, 2020 08:12 am ET
Titan Medical Announces Departure of Director Domenic Serafino
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces that Domenic (Dom) Serafino has resigned as a Director of the Company. Titan has begun the process of seeking qualified candidates to fill this vacancy.
Feb 03, 2020 08:26 am ET
Titan Medical Issues Letter to Shareholders
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces that David McNally, President & CEO, has issued a letter to shareholders.
Jan 27, 2020 08:28 am ET
Titan Medical Receives ISO 13485 Certification, Provides Update on Fourth Quarter Milestones
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), today announced receipt of ISO 13485 Certification from a European Notified Body following completion of audits of the Company’s quality system and related documentation. This certification represents that Titan’s quality management system (“QMS”) maintains standards that meet international requirements specific to medical device design and development.
Jan 06, 2020 07:30 am ET
Titan Medical and Cambridge Design Partnership Announce Expanded Engagement for Robotic Instrument Development
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), and Cambridge Design Partnership Ltd. (“CDP”), a leading patient-centric product and technology innovation company specializing in the healthcare sector, today announce an expanded engagement in respect of the instrument development program for Titan’s single-port robotic surgical system. Additionally, CDP has subscribed for common shares of Titan.
Dec 23, 2019 09:17 am ET
Titan Medical Announces New Common Share Purchase Agreement With Aspire Capital Fund of up to US$35 Million
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has entered into a Common Share Purchase Agreement (the “Agreement”) with Aspire Capital Fund, LLC (“Aspire Capital”) where Aspire Capital has committed to purchase up to US$35.0 million of common shares of Titan at Titan’s request from time to time, until June 23, 2022. This new Agreement replaces the prior Common Share Purchase Agre
Dec 04, 2019 05:00 pm ET
Titan Medical Confirms Receipt of Deficiency Notices From Nasdaq
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that on November 27, 2019, the Company received notification from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5550(a)(2) since the closing bid price for the Company's common shares (the “Shares”) listed on Nasdaq was below
Nov 21, 2019 08:29 am ET
Titan Medical to Participate in Two Investment Conferences in December
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that Company management will be participating in two upcoming investor conferences.
Nov 14, 2019 05:39 pm ET
Titan Medical Reports Third Quarter 2019 Financial Results
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or “the Company”), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the three and nine months ended September 30, 2019.
Nov 07, 2019 08:37 am ET
Titan Medical Determines Not to Proceed with Public Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced today that it has determined not to proceed with the public offering of units of the Company for which it filed a final short form prospectus on October 31, 2019. The Company has made this decision based on its assessment of market conditions, and intends to pursue alternative financing options.
Nov 01, 2019 03:29 pm ET
Titan Medical Announces Filing of Final Prospectus
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it has filed and been receipted for a final short form prospectus (the “Final Prospectus”) in connection with the previously announced marketed offering (the “Offering”) of units of the Company (the “Units”) at a price of US $0.45 per Unit for minimum gross proceeds of US $15,000
Oct 25, 2019 09:39 am ET
IIROC Trade Resumption - TMD
TORONTO, Oct. 25, 2019 /CNW/ - Trading resumes in:
Oct 25, 2019 09:32 am ET
Titan Medical Announces Pricing of Marketed Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it has priced its previously announced marketed offering (the “Offering”) of units of the Company (the “Units”). Pursuant to the Offering, Titan will issue Units at a price of US $0.45 per Unit for total gross proceeds of a minimum of US $15,000,000 and a maximum of US $25
Oct 25, 2019 09:00 am ET
IIROC Trading Halt - TMD
TORONTO, Oct. 25, 2019 /CNW/ - The following issues have been halted by IIROC:
Oct 15, 2019 05:31 pm ET
Titan Medical Announces Filing of Amended and Restated Preliminary Prospectus and Withdrawal of Previously Published Milestones
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced today that it has filed and been receipted for an amended and restated preliminary short form prospectus (the “A&R Preliminary Prospectus”) with securities regulators in the provinces of Ontario, British Columbia and Alberta. Titan has also filed a corresponding registration statement on Form F-1
Oct 01, 2019 08:50 am ET
Titan Medical Continues to Market Offering of Units
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced on Monday, September 23, 2019 that it had filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with securities regulators in the provinces of Ontario, British Columbia and Alberta. Titan had also filed a corresponding registration statement on Form F-10 (the “
Sep 25, 2019 07:59 am ET
IIROC Trade Resumption - TMD
TORONTO, Sept. 25, 2019 /CNW/ - Trading resumes in:
Sep 24, 2019 05:00 pm ET
Titan Medical Continues to Market Offering of Units
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced Monday, September 23, 2019 that it had filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with securities regulators in the provinces of Ontario, British Columbia and Alberta. Titan had also filed a corresponding registration statement on Form F-10 (the “R
Sep 23, 2019 04:59 pm ET
IIROC Trading Halt - TMD
TORONTO, Sept. 23, 2019 /CNW/ - The following issues have been halted by IIROC:
Sep 23, 2019 04:39 pm ET
Titan Medical Announces Overnight Marketed Offering of Units
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced today that it has filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with securities regulators in the provinces of Ontario, British Columbia and Alberta. Titan has also filed a corresponding registration statement on Form F-10 (the “Registration Statement
Sep 06, 2019 09:05 am ET
Titan Medical Announces Change to Presentation Time at H.C. Wainwright Conference
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that management’s presentation at the H.C. Wainwright 21st Annual Global Investment Conference has been moved to 2:35 p.m. Eastern time on Tuesday, September 10. The presentation had previously been scheduled for 4:15 p.m. Eastern time that day. Management’s presentation will be webcast live and a replay will be available on the Investor Rela
Sep 03, 2019 04:26 pm ET
Titan Medical to Webcast Wells Fargo Healthcare Conference Presentation
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that owing to a change in format, management will deliver a corporate presentation at the 2019 Wells Fargo Healthcare Conference at 3:35 p.m. Eastern time on September 4th. The presentation will be webcast live and a replay will be available on the Investor Relations portion of the Company’s website.
Sep 03, 2019 08:54 am ET
Titan Medical Strengthens Robotic Surgery U.S. Patent Portfolio With Grant for Surgical Imaging Technology
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, announces that it has been granted U.S. Patent No. 10,398,287, titled “Camera Positioning System, Method, and Apparatus for Capturing Images During a Medical Procedure.” The patent is directed at aspects of the Company’s innovative dual-view camera system for use in robotic surgery, including single-port robotic surgery.
Aug 29, 2019 05:25 pm ET
Titan Medical Announces Common Share Purchase Agreement With Aspire Capital Fund of up to US$35 Million
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has entered into a Common Share Purchase Agreement (the “Agreement”) with Aspire Capital Fund, LLC (“Aspire Capital”) where Aspire Capital has committed to purchase up to US$35.0 million of common shares of Titan at Titan’s request from time to time, until February 28, 2022. On commencement of the Agreement, Titan will immediately sel
Aug 27, 2019 08:28 am ET
Titan Medical to Present at Upcoming September Investment Conferences
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that management will present at two investment conferences in September.
Aug 26, 2019 08:45 am ET
Titan Medical Announces Successful Completion of Human Factors Evaluation for Its Single-Port Robotic Surgical System, Provides Development and Regulatory Update
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that the human factors evaluation (“HFE”) required to support its planned Investigational Device Exemption (“IDE”) filing with the U.S. Food and Drug Administration (“FDA”) was completed successfully and received a highly favorable assessment from the surgeon investigators.
Aug 06, 2019 08:50 am ET
Titan Medical Announces Successful Completion of Survival Phase of GLP Chronic Procedures with its Single-Port Robotic Surgical System
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces the successful completion of the chronic procedures performed under Good Laboratory Practice (“GLP”) principles using its single-port robotic surgery system, noting that all animals survived through the follow-up period. Ricardo Estape, M.D., a robotic gynecologic oncology surgeon specializing in robotic single incision surgeries from South M
Jul 31, 2019 05:57 pm ET
Titan Medical Reports Second Quarter 2019 Financial Results
Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (“Titan” or “the Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the three and six months ended June 30, 2019.
Jul 23, 2019 08:39 am ET
Jul 18, 2019 08:43 am ET
Titan Medical Completes Preclinical Good Laboratory Practice Procedures With Its Single-Port Robotic Surgical System
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that all procedures under Good Laboratory Practice (“GLP”) principles associated with the acute and chronic animal studies and human cadaver studies using its single-port robotic surgery system have been completed. The Company intends to announce the results of required follow-up to the chronic procedures by the end of August.
Jul 08, 2019 07:30 am ET
Titan Medical Names Surgical Robotics Sales Veteran Chad A. Zaring as its Chief Commercial Officer
(July 8, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that Chad A. Zaring has joined the Company as chief commercial officer, a new position. Mr. Zaring has deep experience developing and executing commercial strategies and driving sales for leading surgical robotics companies and will be responsible for the launch of Titan’s single-port robotic surgery system following receipt
Jun 13, 2019 08:25 am ET
Titan Medical to Present and Exhibit at the Society of Robotic Surgery 2019 Annual Meeting
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that David McNally, President and CEO of Titan Medical, will present in the plenary session titled “Innovations in Robotic Technologies, What The Future Holds In Store” on Thursday, June 20 at the Society of Robotic Surgery 2019 Annual Meeting in Orlando. This industry-focused plenary session w
May 31, 2019 08:57 am ET
Titan Medical Inc. Announces Voting Results from Its Annual and Special Meeting of Shareholders
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery, reported shareholder vote results from the Company’s Annual and Special Meeting held on Wednesday, May 29, 2019.
May 22, 2019 05:15 pm ET
Titan Medical Annual and Special Meeting Scheduled for Wednesday, May 29, 2019
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces that its 2019 Annual and Special Meeting is scheduled for Wednesday, May 29, 2019 at 12:00 p.m. (Eastern), to be held at the Toronto Hilton Hotel, 145 Richmond Street West, Simcoe Room, Main Lobby.
May 14, 2019 06:56 pm ET
Titan Medical Reports First Quarter 2019 Financial Results
Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (“Titan” or “the Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the three months ended March 31, 2019.
May 01, 2019 07:00 am ET
Titan Medical Names Prominent Medical Technology Executive Charles Federico as Chairman of the Board
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces the appointment of Charles W. Federico, age 70, as Chairman of the Company’s Board of Directors, effective immediately. Mr. Federico is assuming the Board seat held by Bruce Wolff, M.D. who has resigned from the Board and is being retained as a Senior Advisor to the Company. Current
Apr 30, 2019 07:00 am ET
Titan Medical Announces Hardware Design Freeze for its Single-port Robotic Surgery System
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces it has achieved hardware design freeze for its single-port robotic surgery system. This design freeze is the culmination of engineering work based on product feedback gathered from extensive preclinical feasibility studies at three Centers of Excellence and ongoing Formative Human
Apr 23, 2019 07:00 am ET
Titan Medical to Present at the Bloom Burton & Co. Healthcare Investor Conference
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO of the Company, will present a corporate overview at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 30 at 1:30 p.m. Eastern time. The conference will be held April 30-May 1 at the Metro Toronto Convention Ce
Mar 25, 2019 07:00 am ET
Titan Medical and Teleflex Incorporated Announce Collaboration for Development of Robotic Ligation Technology
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”) and Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, announce a collaboration under which Teleflex’s market-leading polymer ligation technology will be integrated into Titan’s development-stage, single-port robotic surgery system. Teleflex’s Weck®
Mar 22, 2019 07:30 am ET
Titan Medical to Webcast Business Update Conference Call on March 28, 2019
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that management will webcast a conference call on Thursday, March 28 at 4:30 p.m. ET to provide a business update on the Company and its SPORT Surgical System. Speakers on the call will include David J. McNally, Chief Executive Officer of Titan Medical and Stephen D. R
Mar 21, 2019 04:30 pm ET
Titan Medical Closes Public Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce the closing of its previously announced public offering (the “Offering”) pursuant to an agency agreement dated March 18, 2019 between the Company and Bloom Burton Securities Inc. (the “Agent”).
Mar 19, 2019 07:00 am ET
Titan Medical Announces Filing of Final Prospectus
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce that yesterday it filed and was receipted for a final short form prospectus (the “Final Prospectus”) in connection with the previously announced marketed offering (the “Offering”) of units of the Company (the “Units”). Pursuant to the Offerin
Mar 06, 2019 09:35 am ET
Titan Medical Announces Pricing of Overnight Marketed Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it has priced its previously announced overnight marketed offering (the “Offering”) of units of the Company (the “Units”). Pursuant to the Offering, Titan will issue Units at a price of US $3.40 per Unit for total gross proceeds of a mini
Mar 05, 2019 04:29 pm ET
Titan Medical Announces Overnight Marketed Offering of Units
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced today that it has filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with securities regulators in the provinces of Ontario, British Columbia and Alberta. Titan has also filed a corresponding registration statement on Form F
Feb 27, 2019 09:02 am ET
Titan Medical Expands Global Intellectual Property Portfolio to 30 Patents Issued and 75 Pending with Receipt of First Patent in China
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that its global intellectual property portfolio has increased to 30 issued patents and 75 pending applications through the recent granting and filing of patent applications directed at aspects of its innovative robotic surgery program. Included in the recent patent grants is the Company’s first patent in C
Feb 13, 2019 06:48 pm ET
Titan Medical Reports 2018 Financial Results
Titan Medical Inc. (TSX:TMD) (Nasdaq:TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the year ended December 31, 2018.
Jan 14, 2019 09:00 am ET
Peer-Reviewed Paper Featuring Titan Medical’s Single-Port Robotic Surgical Platform in General Surgery Published in Surgical Endoscopy
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces that a peer-reviewed multi-faculty paper featuring Titan’s single-port platform has been published in the January 2019 issue of Surgical Endoscopy. The paper highlights the feasibility, safety and ease of use of Titan’s single-port robotic technology for general surgery procedures and is
Jan 03, 2019 08:36 am ET
Titan Medical Completes Build of Its Next-Generation Single-Port Robotic Surgical System
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has completed the system engineering confidence build for all components of its single-port robotic surgery system. This accomplishment highlights the completion of a new camera system along with the design enhancements of both the surgeon workstation and the patient cart, the two primary components of
Jan 02, 2019 08:46 am ET
Titan Medical Affirms Timeline for U.S. and EU Regulatory Submissions by Year-End 2019 for Its Sport Surgical System
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), affirms its regulatory filing timeline with a 510(k) submission expected by the end of 2019 as a result of discussions with the U.S. Food and Drug Administration (“FDA”). The Company plans to complete the required human confirmatory studies under an Investigational Device Exemption (“IDE”) during the second half of 2019
Dec 17, 2018 08:00 am ET
Titan Medical Expands Global Patent Portfolio for Single-Port Robotic Surgery with Seven Grants and Notices of Allowance
Titan Medical Inc. (TSX:TMD) (Nasdaq:TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces seven new patent grants and notices of allowance related to its single-port robotic surgery technology, including patents covering multi-articulating instruments, robotic system control and user interfaces. Including these new patents and notices, the Company has 28 issued patents and 70 pending patent applications
Nov 19, 2018 12:48 pm ET
Titan Medical to Present at the 30th Annual Piper Jaffray Healthcare Conference
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO of the Company, will present a corporate overview at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28 at 12:10 p.m. Eastern time. The conference will be held November 27-29, 2018 at the Lotte New York Pa
Nov 15, 2018 04:05 pm ET
Abstract Highlighting Titan Medical’s SPORT Surgical System Presented at the American Association of Gynecologic Laparoscopists Global Congress
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces an abstract titled “Reverse Objective Structured Assessment of Technical Skills (Reverse-OSATS) as a means of measuring the capability of the Titan Medical SPORT Surgical System on core surgical principles” was presented yesterday at the American Association of Gynecologic Laparosco
Nov 12, 2018 04:10 pm ET
Titan Medical Reports Third Quarter 2018 Financial Results
Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (“Titan” or “the Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the three and nine months ended September 30, 2018.
Nov 07, 2018 08:30 am ET
Titan Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO of the Company, will present a corporate overview at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15 at 2:00 p.m. Eastern time. The Medical Technologies & Diagnostics Forum will be held November 15,
Oct 23, 2018 08:00 am ET
Titan Medical to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO of the Company, will present a corporate overview at the Dawson James Securities 4th Annual Small Cap Growth Conference on Tuesday, October 30 at 11:00 a.m. Eastern time. The conference will be held October 29-30, 2018 at Wyndha
Oct 04, 2018 08:43 am ET
Titan Medical Achieves all Third Quarter Milestones Related to the Development of the SPORT Surgical System
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery...
Sep 18, 2018 09:15 am ET
Titan Medical and Mimic Technologies Announce Successful Completion of Core Surgical Skills Simulation Modules
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”)...
Sep 12, 2018 04:30 pm ET
Titan Medical to Webcast Business Update and Outlook Conference Call on September 20, 2018
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced...
Sep 06, 2018 07:15 am ET
Abstract Featuring Titan Medical’s SPORT Surgical System Presented at the European Association of Urology Robotic Urology Section Annual Meeting
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery...
Aug 28, 2018 07:15 am ET
Titan Medical Granted U.S. Patent for Instrument Insertion and Positioning in Single-Port Robotic Surgery
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has been...
Aug 27, 2018 07:15 am ET
Titan Medical to Present at Two Investment Conferences in September
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that David...
Aug 13, 2018 08:48 am ET
Titan Medical Reports Second Quarter 2018 Financial Results
Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (“Titan” or “the Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results...
Aug 10, 2018 01:54 pm ET
Titan Medical Announces Closing of Previously Announced Public Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased...
Aug 07, 2018 04:11 pm ET
Titan Medical Announces Filing of Final Prospectus and Pricing of Marketed Offering of Units
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased...
Aug 02, 2018 07:15 am ET
Titan Medical Expands Advisory Role for Dr. Arnold Advincula to Include Clinical Education and Hospital Economics
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (NASDAQ: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery...
Jul 09, 2018 07:15 am ET
Titan Medical Announces Achievement of all Second Quarter 2018 SPORT Surgical System Development Milestones
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”),...
Jun 28, 2018 05:25 pm ET
Titan Medical Announces Marketed Offering of Units
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces...
Jun 28, 2018 07:15 am ET
Titan Medical Appoints Medtech Industry Veteran Domenic Serafino to Its Board of Directors
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces...
Jun 27, 2018 07:15 am ET
Titan Medical Common Stock to Trade on Nasdaq
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), today...
Jun 20, 2018 07:15 am ET
Titan Medical’s Head of Intellectual Property Recognized as a Global IP Strategy Leader by Intellectual Asset Management
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXD), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, announces that...
Jun 19, 2018 07:15 am ET
Titan Medical Announces Completion of 1-for-30 Reverse Stock Split
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, announces that it...
Jun 15, 2018 07:15 am ET
Titan Medical Announces Voting Results From Its Annual AND SPECIAL Meeting of Shareholders
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, reported...
Jun 13, 2018 07:15 am ET
Titan Medical to Present and Exhibit at the Society of Robotic Surgery 2018 Annual Meeting
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces...
Jun 01, 2018 07:15 am ET
Titan Medical Applies to List Its Common Shares on Nasdaq, Announces 1-for-30 Reverse Stock Split
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces...
May 14, 2018 08:00 am ET
Titan Medical Reports First Quarter 2018 Financial Results
Titan Medical Inc. (TSX:TMD) (OTCQB:TITXF) (“Titan” or “the Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results...
May 10, 2018 08:51 am ET
Titan Medical Announces Closing of Over-Allotment Option
Titan Medical Inc. (the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce...
Apr 27, 2018 12:33 pm ET
Titan Medical’s Presentation Date at the 2018 Bloom Burton & Co. Healthcare Investor Conference Moved to May 3
TORONTO, April 27, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive...
Apr 24, 2018 09:30 am ET
Titan Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Apr 16, 2018 07:52 am ET
Abstract Highlighting the Early European Experience With Titan Medical’s SPORT Surgical System Presented at the Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting
TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Apr 10, 2018 09:14 am ET
Titan Medical Announces Closing of Previously Announced Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Apr 03, 2018 05:31 pm ET
Titan Medical Announces Filing of Final Prospectus
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Mar 29, 2018 07:30 am ET
Titan Medical and Mimic Technologies Announce Collaboration and Successful Demonstration of First Simulation Modules
TORONTO and SEATTLE, March 29, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally...
Mar 27, 2018 09:00 am ET
Titan Medical Granted U.S. Patent for Robotic Surgical Instruments
TORONTO, March 27, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Mar 15, 2018 05:15 pm ET
Titan Medical Announces Director Resignation
TORONTO, March 15, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Mar 15, 2018 07:30 am ET
Titan Medical to Present at the 28th Annual Oppenheimer Healthcare Conference
TORONTO, March 15, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (TSX:TMD) (OTCQB:TITXF) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”),...
Mar 07, 2018 09:19 am ET
Titan Medical Announces Pricing of Marketed Offering of Units
TORONTO, March 07, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Mar 06, 2018 04:21 pm ET
Titan Medical Announces Marketed Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Mar 01, 2018 12:00 am ET
Titan Medical to Present at the 30th Annual ROTH Conference
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (TSX:TMD) (OTCQB:TITXF) (“Titan” or “the Company), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”),...
Feb 27, 2018 07:30 am ET
Titan Medical Granted Patent Related to Instrument End-Effector for Use in Robotic Surgery
TORONTO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Feb 13, 2018 05:01 pm ET
Titan Medical Reports 2017 Financial Results
TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (TSX:TMD) (OTCQB:TITXF) (“Titan” or “the Company), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”),...
Jan 30, 2018 01:11 pm ET
Titan Medical to Host Business Update Conference Call on February 6, 2018
TORONTO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Dec 20, 2017 07:30 am ET
Titan Medical Reports First Use of SPORT Surgical System in Europe at the Institute of Image-Guided Surgery of Strasbourg
TORONTO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Dec 13, 2017 07:30 am ET
Titan Medical Strengthens Patent Portfolio With Issuance of Two Canadian Patents and Allowance of a Japanese Patent
TORONTO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Dec 06, 2017 07:30 am ET
Titan Medical and the Institute of Image-Guided Surgery of Strasbourg Announce the First Installation of SPORT Surgical System in Europe
TORONTO, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery...
Dec 05, 2017 09:07 am ET
Titan Medical Announces Closing of Previously Announced Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Dec 01, 2017 02:15 pm ET
Titan Medical Announces Filing of Final Prospectus
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Nov 23, 2017 11:44 am ET
Titan Medical Announces Filing of Second Amended and Restated Preliminary Prospectus
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Nov 20, 2017 05:00 pm ET
Titan Medical Announces Upsizing of Previously Announced Marketed Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Nov 17, 2017 01:09 pm ET
Titan Medical Announces Filing of Amended and Restated Preliminary Prospectus
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Nov 16, 2017 07:30 am ET
Titan Medical Reports First Use of Sport Surgical System at Columbia University Medical Center
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"), announces...
Nov 15, 2017 09:35 am ET
Titan Medical Announces Pricing of Marketed Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF) is pleased to announce today that it has priced its previously announced...
Nov 14, 2017 05:18 pm ET
Titan Medical Inc. Announces Marketed Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF) announces today that it has filed and been receipted for a preliminary short...
Nov 09, 2017 05:15 pm ET
Titan Medical Reports Third Quarter 2017 Financial Results
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF) ("Titan" or "the Company), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"), announces financial results...
Nov 06, 2017 05:15 pm ET
Titan Medical to Hold Business Update Conference Call on November 13, 2017
Titan Medical Inc. ("Titan" or the " Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"),...
Oct 31, 2017 08:30 am ET
Titan Medical Announces Final Closing of CDN $3.3 Million Private Placement Led by Group of U.S. Robotic Surgeons
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Titan Medical Inc. ("Titan" or the " Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and...
Oct 26, 2017 07:30 am ET
Titan Medical Receives CDN $8.4 Million From Warrant Exercise
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and...
Oct 23, 2017 07:30 am ET
Titan Medical and Columbia University Medical Center Announce the Successful Installation of Titan's Sport Surgical System
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"), and...
Oct 20, 2017 08:41 am ET
Titan Medical Announces Closing of CDN $2.9 Million Private Placement Led by Group of U.S. Robotic Surgeons
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the " Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and...
Sep 28, 2017 06:00 am ET
Titan Medical Partners With Columbia University Medical Center for Sport Feasibility and Validation Studies
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces it...
Sep 25, 2017 08:55 am ET
Titan Medical Reports Success With World's First Gynecologic, Colorectal and Urologic Single Port Robotic Procedures Performed Using Sport Surgical System
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces...
Sep 18, 2017 07:30 am ET
Titan Medical and Florida Hospital Nicholson Center Announce the World's First Installation of Sport Surgical System
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), and Florida...
Sep 05, 2017 11:52 am ET
Titan Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that David McNally, President and CEO of...
Aug 24, 2017 07:35 pm ET
Titan Completes Agreement With Longtai Medical Inc. for Equity Conversion of Distributorship Deposit
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF) ("Titan" or the "Company"), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"), announced...
Aug 22, 2017 07:00 am ET
Titan Medical Partners With Institut Hospitalo-Universitaire de Strasbourg for SPORT Feasibility and Validation Studies
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"), announces...
Aug 08, 2017 05:25 pm ET
Titan Medical Reports Second Quarter 2017 Financial Results
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), announces financial results for the three and six months...
Aug 01, 2017 07:30 am ET
Longtai Medical Agrees to Convert Titan Medical's Distributorship Deposit to Equity
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF) ("Titan" or the "Company"), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"), announces...
Jul 28, 2017 08:37 am ET
Titan Medical Announces Closing of Previously Announced Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. (the "Company") (TSX: TMD) (OTCQB: TITXF) is pleased to announce that it has completed its previously announced public offering (the...
Jul 21, 2017 08:43 am ET
Titan Medical Inc. Announces Second Closing of Previously Announced Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Titan Medical Inc. (the "Company") (TSX: TMD) (OTCQB: TITXF) is pleased to announce that it has completed the second closing (the "Second Closing") of...
Jul 10, 2017 07:59 am ET
Titan Medical Partners With Florida Hospital Nicholson Center for SPORT Feasibility and Validation Studies
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces a...
Jun 29, 2017 09:25 am ET
Titan Medical Inc. Announces Closing of Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. (the "Company") (TSX: TMD) (OTCQB: TITXF) is pleased to announce that it closed its previously announced public offering (the...
Jun 27, 2017 04:22 pm ET
Titan Medical Inc. Announces Filing of Final Prospectus for Marketed Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF) announced today that it has filed a final short form prospectus in connection...
Jun 20, 2017 11:12 am ET
IIROC Trade Resumption - TMD
TORONTO, June 20, 2017 /CNW/ - Trading resumes in:
Jun 20, 2017 11:02 am ET
IIROC Trading Halt - TMD
TORONTO, June 20, 2017 /CNW/ - The following issues have been halted by IIROC:
Jun 20, 2017 09:54 am ET
Titan Medical Inc. Announces Pricing of Marketed Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF) is pleased to announce today that it has priced its previously announced...
Jun 19, 2017 07:30 am ET
Titan Medical Named Best Canadian IP Department at 2017 International Legal Alliance Summit & Awards
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), was named...
Jun 16, 2017 09:00 am ET
Titan Medical Announces Voting Results From Its Annual and Special Meeting of Shareholders
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, reported...
Jun 09, 2017 12:21 pm ET
IIROC Trade Resumption - TMD
TORONTO, June 9, 2017 /CNW/ - Trading resumes in:
Jun 09, 2017 11:52 am ET
IIROC Trading Halt - TMD
TORONTO, June 9, 2017 /CNW/ - The following issues have been halted by IIROC:
Jun 09, 2017 11:05 am ET
Titan Medical Inc. Announces Marketed Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF) announced today that it has filed a preliminary short form prospectus in...
Jun 07, 2017 07:30 am ET
Titan Medical Granted European Patent Related to SPORT Surgical System Robotic Instruments
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces the publication of European...
May 17, 2017 08:47 am ET
Titan Medical Completes Initial Formative Human Factors Studies for SPORT Robotic Surgical System
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), announces completion of initial formative human factors...
May 11, 2017 04:30 pm ET
Titan Medical Reports First Quarter 2017 Financial Results
Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), announces financial results for the three months ended...
Apr 28, 2017 09:58 am ET
Titan Medical Ends Negotiations With Longtai Medical for Sport Distribution in Asia Pacific
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) (Titan), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces it has terminated its...
Apr 26, 2017 09:03 am ET
Titan Medical Issued U.S. Patent Related to SPORT Surgical System Robotic Instruments
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces the issuance of U.S. Patent...
Apr 24, 2017 09:41 am ET
Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference 2017
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that David McNally,...
Apr 03, 2017 09:16 am ET
Titan Medical Appoints Curtis R. Jensen Vice President of Quality and Regulatory Affairs
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces the appointment of Curtis R....
Mar 23, 2017 08:32 am ET
Titan Medical Finalizes User Requirements for 1st Generation Robotic Surgical System; Reiterates 2017 and 2018 Development Milestones Leading to FDA 510(k) Submission
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), reported today that the first milestone for 2017, finalizing user requirements for the single port robotic surgical system, has been achieved slightly ahead of schedule. The Company also reiterated the...
Mar 21, 2017 05:01 pm ET
Titan Medical Reports Financial Results for Fiscal Year Ended December 31, 2016
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), today announced financial results for...
Mar 17, 2017 07:30 am ET
Titan Medical Schedules Conference Call to Review Fourth Quarter Financial Results and Recent Corporate Developments
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that it will report its...
Mar 16, 2017 09:58 am ET
Titan Medical Inc. Announces Closing of Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. (the "Company") (TSX: TMD) (OTCQX: TITXF) is pleased to announce that it closed its previously announced public offering (the...
Mar 10, 2017 10:19 pm ET
Titan Medical Inc. Announces Filing of Prospectus Supplement
Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) is...
Mar 09, 2017 07:30 am ET
Titan Medical to Present at 29th Annual ROTH Conference on March 14
Titan Medical, Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that David McNally, President and CEO of...
Mar 08, 2017 10:49 am ET
IIROC Trade Resumption - TMD
TORONTO, March 8, 2017 /CNW/ - Trading resumes in:
Mar 08, 2017 10:40 am ET
Titan Medical Inc. Announces Pricing of Overnight Marketed Equity Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) is pleased to announce today that it has priced its previously announced...
Mar 07, 2017 04:29 pm ET
IIROC Trading Halt - TMD
TORONTO, March 7, 2017 /CNW/ - The following issues have been halted by IIROC:
Mar 07, 2017 04:02 pm ET
Titan Medical Inc. Announces Overnight Marketed Equity Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) announced today that it will undertake an overnight marketed public offering...
Feb 06, 2017 09:00 am ET
Titan Medical Appoints Perry A. Genova Vice President of Research and Development
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that Perry A. Genova, PhD, a senior...
Jan 25, 2017 09:06 am ET
Titan Medical to Present at 13th Annual Noble Conference on January 30
Titan Medical, Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that David McNally, President and CEO of...
Jan 09, 2017 11:58 am ET
IIROC Trade Resumption - TMD
TORONTO, Jan. 9, 2017 /CNW/ - Trading resumes in:
Jan 09, 2017 11:49 am ET
Titan Medical Announces Senior Management Change
Titan Medical Inc. (the "Company") (TSX: TMD) (OTCQX: TITXF) takes this opportunity to provide an update.As of today's date, Dr. Reiza Rayman has resigned as President of Titan Medical Inc. Dr. Rayman co-founded the Company in July 2008, with a view...
Jan 09, 2017 11:32 am ET
IIROC Trading Halt - TMD
TORONTO, Jan. 9, 2017 /CNW/ - The following issues have been halted by IIROC:
Jan 03, 2017 08:00 am ET
Healthcare Industry Leader David J. McNally Named CEO of Titan Medical Inc.
David J. McNally, an executive who has successfully created and developed two medical device companies while generating significant shareholder value, has been appointed Chief Executive Officer and a Director of Titan Medical Inc. (TSX: TMD) (OTCQX:...
Nov 08, 2016 04:14 pm ET
Titan Medical Reports Financial Results for Third Quarter Ended September 30, 2016
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today announced financial results for the three and nine...
Nov 02, 2016 07:30 am ET
Titan Medical Included in Recently Launched OTCQX Canada Index
Titan Medical Inc. (OTCQX: TITXF) (TSX: TMD), OTC Markets Group Inc. (OTCQX: OTCM), announced that the Company is included in the newly launched OTCQX Canada Index, which includes a diversity of high-quality Canadian companies that meet the high...
Oct 27, 2016 09:03 am ET
Titan Medical Inc. Announces Closing of Over-Allotment Option
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTitan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) is pleased to announce that the over-allotment option (the "Over-Allotment...
Oct 13, 2016 07:30 am ET
Titan Medical and Ximedica Resume Development of the Sport Surgical System
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) today reported that the Company and its principal development partner, Ximedica LLC have reached agreement on the initiation of an acceptable development plan for the SPORT™ Surgical System. The agreement...
Oct 11, 2016 08:59 am ET
Titan Medical Board of Directors Initiates Leadership Changes
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) today reported that the Company's Board of Directors has initiated a leadership change strategy in order to expedite the development of the SPORT™ Surgical System. The initial steps of the strategy...
Sep 27, 2016 04:05 pm ET
Titan Medical Provides Corporate Update
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today provided an update of corporate activities and...
Sep 20, 2016 10:14 am ET
IIROC Trade Resumption - TMD.WT.I
TORONTO, Sept. 20, 2016 /CNW/ - Trading resumes in:
Sep 20, 2016 09:14 am ET
IIROC Trading Halt - TMD.WT.I
TORONTO, Sept. 20, 2016 /CNW/ - The following issues have been halted by IIROC: